{"id":4867,"date":[],"date_gmt":"2024-07-15T15:03:58","guid":{"rendered":"https:\/\/hcp.biomarin.com\/en-gb\/achondroplasia\/expert\/?post_type=resource&p=4867"},"modified":"2024-07-15T15:03:59","modified_gmt":"2024-07-15T15:03:59","slug":"growth-promoting-effects-of-vosoritide%e2%96%bcin-children-with-achondroplasia-aged-%e2%89%a510-years-at-treatment-initiation-results-from-a-phase-3-extension-study","status":"publish","type":"resource","link":"https:\/\/hcp.biomarin.com\/en-gb\/achondroplasia\/expert\/resource\/growth-promoting-effects-of-vosoritide%e2%96%bcin-children-with-achondroplasia-aged-%e2%89%a510-years-at-treatment-initiation-results-from-a-phase-3-extension-study\/","title":{"rendered":"Growth-promoting effects of vosoritide\u25bcin children with achondroplasia aged \u226510 years at treatment initiation: Results from a Phase 3 extension study"},"content":{"rendered":"","protected":false},"author":18,"template":"","format":[30],"topic":[],"key_opinion_leader":[],"audience":[],"disease_state":[],"region":[],"product":[],"acf":[],"yoast_head":"\n